<strike id="amuic"></strike>
  • <abbr id="amuic"><option id="amuic"></option></abbr>
    <strike id="amuic"></strike>
  • <cite id="amuic"><source id="amuic"></source></cite>
    <cite id="amuic"><source id="amuic"></source></cite>
  • <ul id="amuic"><table id="amuic"></table></ul>
    最近搜索:細胞培養 微生物學 分子生物 生物化學
    首頁>>免疫學>>一抗>>絲氨酸/蘇氨酸蛋白激酶TNN13K抗體
    絲氨酸/蘇氨酸蛋白激酶TNN13K抗體
    • 產品貨號:
      BN41389R
    • 中文名稱:
      絲氨酸/蘇氨酸蛋白激酶TNN13K抗體
    • 英文名稱:
      Rabbit anti-TNNI3K Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產品規格

      售價

      備注

    • BN41389R-100ul

      100ul

      ¥2360.00

      交叉反應:Human,Rat(predicted:Mouse,Chicken,Cow,Horse,Rabbit,Sheep) 推薦應用:WB,IHC-P,IHC-F,IF,ELISA

    • BN41389R-200ul

      200ul

      ¥3490.00

      交叉反應:Human,Rat(predicted:Mouse,Chicken,Cow,Horse,Rabbit,Sheep) 推薦應用:WB,IHC-P,IHC-F,IF,ELISA

    產品描述

    英文名稱TNNI3K
    中文名稱絲氨酸/蘇氨酸蛋白激酶TNN13K抗體
    別    名Cardiac ankyrin repeat kinase; CARK; MGC142099; MGC33828; Serine/threonine protein kinase TNN13K; Serine/threonine-protein kinase TNNI3K; TNI3K_HUMAN; TNNI3 interacting kinase; TNNI3-interacting kinase; Tnni3k.  
    研究領域腫瘤  心血管  免疫學  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應Human, Rat,  (predicted: Mouse, Chicken, Cow, Horse, Rabbit, Sheep, )
    產品應用WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蠟切片需做抗原修復)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量93kDa
    細胞定位細胞核 細胞漿 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthetic peptide derived from human TNNI3K:1-100/835 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產品介紹TNNI3K, also known as CARK, is a 936 amino acid serine/threonine-protein kinase that is highly expressed in heart. Overexpression of TNNI3K leads to improved cardiac function by enhancing beating frequency and increasing contractile force and epinephrine response. TNNI3K suppresses phosphorylation of cardiac troponin I and p38/JNK-mediated apoptosis, therefore protecting the myocardium from ischemic injury. Administration of TNNI3K to mice with myocardial infarction improves cardiac performance and attentuates ventricular remodeling, suggesting that TNNI3K could be a promising target in the treatment of cardiac diseases. There are four isoforms of TNNI3K that are produced as a result of alternative splicing events.

    Function:
    May play a role in cardiac physiology.

    Subunit:
    Interacts with TNNI3, ACTC, ACTA1, MYBPC3, AIP, BABP3 and HADHB.

    Subcellular Location:
    Nucleus. Cytoplasm. Expressed at lower levels in the cytoplasm.

    Tissue Specificity:
    Highly expressed in both adult and fetal heart.

    Post-translational modifications:
    Autophosphorylated.

    Similarity:
    Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily.
    Contains 10 ANK repeats.
    Contains 1 protein kinase domain.

    SWISS:
    Q59H18

    Gene ID:
    51086

    Database links:

    Entrez Gene: 51086 Human

    Entrez Gene: 435766 Mouse

    Entrez Gene: 295531 Rat

    SwissProt: Q59H18 Human

    SwissProt: Q5GIG6 Mouse

    SwissProt: Q7TQP6 Rat

    Unigene: 729320 Human

    Unigene: 210428 Mouse

    Unigene: 3434 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.